{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:38:07Z","timestamp":1786653487108,"version":"build-2736575974"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Cancer"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4103\/0019-509x.172504","type":"journal-article","created":{"date-parts":[[2015,12,23]],"date-time":"2015-12-23T05:39:04Z","timestamp":1450849144000},"page":"105","source":"Crossref","is-referenced-by-count":3,"title":["Predictive value of recurrence for serum hypoxia inducible factor-1\u03b1 C-reaction protein in hepatocellular carcinoma patients after transcatheter arterial chemoembolization"],"prefix":"10.4103","volume":"52","author":[{"given":"L","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Jianyong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Jiming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Shuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Rui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0019-509X.172504-1","first-page":"10","volume-title":"Cancer statistics, 2012","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"key-10.4103\/0019-509X.172504-2","first-page":"69","volume-title":"Global cancer statistics","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"key-10.4103\/0019-509X.172504-3","first-page":"1632","volume-title":"Guide for diagnosis and treatment of hepatocellular carcinoma","author":"Attwa","year":"2015","journal-title":"World J Hepatol"},{"key":"key-10.4103\/0019-509X.172504-4","first-page":"1412","volume-title":"Current systemic treatment of hepatocellular carcinoma: A review of the literature","author":"Chen","year":"2015","journal-title":"World J Hepatol"},{"key":"key-10.4103\/0019-509X.172504-5","first-page":"479805","volume-title":"Transcatheter arterial chemoembolization based on hepatic hemodynamics for hepatocellular carcinoma","author":"Murata","year":"2013","journal-title":"ScientificWorldJournal"},{"key":"key-10.4103\/0019-509X.172504-6","first-page":"129","volume-title":"Treatment of hepatocellular carcinoma: Beyond international guidelines","author":"Colombo","year":"2015","journal-title":"Liver Int"},{"key":"key-10.4103\/0019-509X.172504-7","first-page":"223","volume-title":"Global epidemiology of hepatocellular carcinoma: An emphasis on demographic and regional variability","author":"McGlynn","year":"2015","journal-title":"Clin Liver Dis"},{"key":"key-10.4103\/0019-509X.172504-8","first-page":"201","volume-title":"Combination of local transcatheter arterial chemoembolization and systemic anti-angiogenic therapy for unresectable hepatocellular carcinoma","author":"Liapi","year":"2012","journal-title":"Liver Cancer"},{"key":"key-10.4103\/0019-509X.172504-9","first-page":"106","volume-title":"The effect of serum VEGF and C-protein expression in predicting the recurrence of elderly patients with liver cancer","author":"Jian","year":"2014","journal-title":"Chin J Gerontol"},{"key":"key-10.4103\/0019-509X.172504-10","first-page":"164\u201371","volume-title":"The efficacy of hepatic arterial infusion chemotherapy as an alternative to sorafenib in advanced hepatocellular carcinoma","author":"Jeong","year":"2012","journal-title":"Asia-Pacific Journal of Clinical Oncology"},{"key":"key-10.4103\/0019-509X.172504-11","first-page":"1623","volume-title":"Role of hypoxia-inducible factors in breast cancer metastasis","author":"Gilkes","year":"2013","journal-title":"Future Oncol"},{"key":"key-10.4103\/0019-509X.172504-12","first-page":"2170","volume-title":"The role of hypoxia-inducible factors in cancer","author":"Maynard","year":"2007","journal-title":"Cell Mol Life Sci"}],"container-title":["Indian Journal of Cancer"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:38:17Z","timestamp":1786649897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0019-509X.172504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"alternative-id":["172504"],"URL":"https:\/\/doi.org\/10.4103\/0019-509x.172504","relation":{},"ISSN":["0019-509X"],"issn-type":[{"value":"0019-509X","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}